Lv6
2930 积分 2023-11-17 加入
Prospective observational study to assess the prognosis of patients with myeloproliferative neoplasms in Japan (MPN-15): results of baseline analysis
17小时前
已完结
Real-world treatment landscape and disease burden of myelofibrosis in Taiwan, South Korea, Japan, and Canada
17小时前
已完结
Eltrombopag may induce bone marrow fibrosis in allogeneic hematopoietic stem cell transplant recipients with prolonged thrombocytopenia
18天前
已完结
Differences in presenting features, outcome and prognostic models in patients with primary myelofibrosis and post-polycythemia vera and/or post-essential thrombocythemia myelofibrosis treated with ruxolitinib. New perspective of the MYSEC-PM in a large multicenter study⁎
2个月前
已完结
The impact of ruxolitinib on thrombosis in patients with polycythemia vera and myelofibrosis
2个月前
已完结
Experimental JAK inhibitors: the current, present, and future in graft-versus-host disease management?
2个月前
已完结
MoReLife – real-life data support the potential of momelotinib as a safe and effective treatment option for cytopenic myelofibrosis patients
3个月前
已完结
Innovation in Alopecia Areata
4个月前
已完结
Complete hair regrowth in a patient with severe alopecia areata treated with deucravacitinib
4个月前
已完结
A systematic review of the efficacy of TYK2 inhibitors in patients with dermatological disease
4个月前
已完结
皖公网安备34019202002308
